COVID-19 tanısı alan bireylerin immün plazma bağışı hakkında bilgi, tutum ve davranışlarının belirlenmesi

Öz

Amaç: İmmün plazma tedavisi, pandemi koşullarında etkili ve kanıtlanmış bir tedavi bulunana kadar etkili bir çözümdür. Bu süreçte immün plazma bağışçısı olmayı kabul eden çok sayıda gönüllüye gereksinim vardır. Bağışçıların, plazma bağışına ilişkin çekinceleri hakkında bilgi sahibi olmak gönüllü bağışçı kazanımı konusunda yol gösterici olacaktır. Bu araştırmanın amacı, Covid 19 tanısı alan bireylerin immün plazma bağışı konusundaki bilgi, tutum ve davranışlarını değerlendirmektir. Materyal ve Metot: Bu araştırma kesitsel bir araştırmadır. Araştırmaya Ocak- Mayıs 2021 tarihleri arasında, bir eğitim ve araştırma hastanesi Covid 19 kliniklerinde tedavi almakta olan, 18-60 yaş arasındaki bireyler dâhil edilmiştir. Bulgular: Katılımcıların yaş ortalaması 43,79 ±1 1,47, %45.5’i (n=100) kadın, %55’i (n=120) erkekti. Katılımcıların %46.36’sı immün plazma bağışçısı olmayı düşünmektedir. İmmün plazma bağışçısı olmaya engel olan faktörlerin başında ise ‘Sağlığımı olumsuz etkileyebilir’ düşüncesi gelmektedir. Katılımcıların yarısı ülkede yeterli immün plazma bağışının yapılıp yapılmadığını bilmemektedir. Sonuç: Pandemi sürecinde sağlık bakım sisteminin immün plazma bağışı konusunda güçlendirilmesi gerekmektedir. Ayrıca halkın bağış konusunda çekincelerinin giderilmesi için çalışmalar yapılmalıdır.

Anahtar Kelimeler

• İmmün plazma
• gönüllü
• bağışçı
• Covid-19
• pandemi

Determination of information, attitudes and behaviors about immune plasma donation of individuals diagnosed with COVID-19

Öz

Background: Immune plasma therapy is an effective solution in pandemic conditions until an effective and proven treatment is found. In this process, a large number of volunteers who accept to be immune plasma donors are needed. Therefore, being informed about the hesitation of the donors regarding plasma donation will be a guide for voluntary donor recruitment. The aim of this research was to evaluate the knowledge, attitudes, and behaviors of individuals diagnosed with Covid 19 about immune plasma donation. Materials and Methods: This is cross-sectional research. Between January and May 2021, individuals between the ages of 18 and 60 who received treatment in a training and research hospital's Covid 19 clinics were included. Results: The mean age of the participants was 43.79±11.47 years, 45.5% (n=100) female and 55% (n=120) male. 46.36% of the participants are considering becoming immune plasma donors. One of the factors that prevent being an immune plasma donor is the thought that "it may negatively affect my health. "Half of the participants do not know whether sufficient immune plasma donation is made in the country. Conclusions: The health care system needs to be strengthened about immune plasma donation during the pandemic process. In addition, efforts should be made to eliminate the hesitations of the public about donations.

Anahtar Kelimeler

• Immune plasma
• Volunteer
• Donor
• Covid 19
• Pandemic
• İmmün plazma
• gönüllü
• bağışçı
• Covid-19
• pandemi

Kaynakça

1. Beköz, H.S., Bilgen, H., & Anak, S.S. (2020). Convalescent Plasma Treatment and Results in COVID-19 Infections. Journal of Advanced Research in Health Sciences, 3(1), 68-77.
2. Burgdorf, K.S., Simonsen, J., Sundby, A., Rostgaard, K., Pedersen, O.B., Sorensen, E., …& Erikstrup, C. (2017). Socio-demographic characteristics of Danish blood donors. PLoS ONE, 12(2), 1-11.
3. Dhiman, Y., Coshic, P., Pandey, H.C., Khatiwada, B., Singh, J., Mehta, V., & Gupta, S. (2021). Deterrents in recruitment of COVID‐19 convalescent plasma donors: Experience from a hospital‐based blood centre in India. Transfusion Medicine, 31(3), 149-154.
4. Erdoğan, S., Nahcivan, N., & Esin, M. N. (Eds.). (2015). Research in Nursing: Process, Application and Criticism (2nd ed.). Istanbul: Nobel Medical Bookstores
5. Ferguson, E. (2015). Mechanism of altruism approach to blood donor recruitment and retention: a review and future directions. Transfusion Medicine, 25(4), 211-226.
6. Ferguson, E., Murray, C., & O’Carroll, R.E. (2019). Blood and organ donation: health impact, prevalence, correlates, and interventions. Psychology & Health, 34(9), 1073-1104.
7. Hacıbekiroğlu, T., Yiğenoğlu, T.N., & Kalpakcı, Y. (2020). Convalescent (Immune) Plasma Therapy in the Treatment of Critical Patients Infected with SARS-Cov-2 Virus. Journal of Biotechnology and Strategic Health Research, 4, 128-134.
8. Kebede, A. A., Bitew, Y., Birku, T., Member, Z., Achenef, W., Tibebu, N. S., & Anteneh, T. A. (2022). Willingness to donate blood and associated factors among patient caregivers at the University of Gondar Comprehensive Specialized Hospital, northwest Ethiopia. Clinical Epidemiology and Global Health, 13, 100953.

9. Lee, C.K. (2020). Impact of severe acute respiratory syndrome on blood services and blood in Hong Kong in 2003. Transfusion Medicine, 30(3), 169-171.
10. Masser, B.M., Ferguson, E., Thorpe, R., Lawrence, C., Davison, T.E., Hoad, V., & Gosbell, I.B. (2021). Motivators of and barriers to becoming a COVID‐19 convalescent plasma donor: A survey study. Transfusion Medicine, 31(3), 176-185.
11. Masser, B.M., Hyde, M.K., & Ferguson, E. (2020). Exploring predictors of Australian community members' blood donation intentions and blood donation–related behavior during the COVID‐19 pandemic. Transfusion, 60 (12), 2907-2917.
12. Patel, E.U., Bloch, E.M., Grabowski, M.K., Goel, R., Lokhandwala, P.M., Brunker, P.A.,...& Tobian, A.A. (2019). Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population‐based study. Transfusion, 59(9), 2899-907.
13. Rajendran, K., Krishnasamy, N., Rangarajan, J., Rathinam, J., Natarajan, M., & Ramachandran, A. (2020). Convalescent plasma transfusion for the treatment of COVID‐19: Systematic review. Journal Of Medical Virology, 92(9), 1475-1483.
14. Sayedahmed, A.M., Ali, K.A., Ali, S.B., Ahmed, H.S., Shrif, F.S., & Ali, N.A. (2020). Coronavirus disease (COVID‐19) and decrease in blood donation: a cross‐sectional study from Sudan. ISBT Science Series, 15(4), 381-385.
15. Stanworth, S.J., New, H.V., Apelseth, T.O., Brunskill, S., Cardigan, R., Doree, C.,… & Shehata, N. (2020). Effects of the COVID-19 pandemic on supply and use of blood for transfusion. The Lancet Haematology, 7(10), 756-764.
16. Suluhan, D., Eker, İ., Yıldız, D., Yılmaz, S., Kızıler, E., Savaşçı, Ü.,..& Beşirbellioğlu, B.A. (2016). Determination the knowledge, attitude and motivation of voluntary blood donors about being hematopoietic stem cell donor. TAF Preventive Medicine Bulletin, 15(6), 512-517.
17. Tagny, C.T., Lendem, I., Ngo Sack, F., Ngo Balogog, P., Ninmou, C., Dongmo, A.,.. & Tapko, J.B. (2020). Trends in blood donations, blood donors’ knowledge, practices and expectations during the COVID‐19 pandemic in Cameroon. Vox Sanguinis, 13, 1-8.
18. World Health Organization. (2020). Guidance on maintaining a safe and adequate blood supply during the coronavirus disease 2019 (COVID-19) pandemic and on the collection of COVID-19 convalescent plasma: Interim guidance. Retrieved from https://apps.who.int/iris/handle/10665/333182